Spire Wealth Management Oncternal Therapeutics, Inc. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$1.37 - $2.43 $6,166 - $10,937	-4,501 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$2.27 - $4.39 $10,217 - $19,759	4,501 New	4,501 $10,000
Q2 2021 Jul 26, 2021	SELL	$4.75 - $9.39 $30,875 - $61,035	-6,500 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$4.59 - $9.04 $29,835 - $58,759	6,500 New	6,500 $49,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $63.8M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.